Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study-Reference-Cited by-同舟云学术

Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study

Published:2009-09 Issue:3 Volume:56 Page:495-503
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Böhle Andreas,Leyh Herbert,Frei Christian,Kühn Michael,Tschada Reinhold,Pottek Tobias,Wagner Walter,Knispel Helmut H.,von Pokrzywnitzki Wolfgang,Zorlu Ferruh,Helsberg Karin,Lübben Birgit,Soldatenkova Victoria,Stoffregen Clemens,Büttner Hartwig

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

2. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials;Sylvester;J Urol,2004

3. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder;Babjuk;Eur Urol,2008

4. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007

5. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study;Grimm;J Urol,2003

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perfusion drugs for non‑muscle invasive bladder cancer (Review);Oncology Letters;2024-04-15

2. Efficacy and safety of short-term intravesical gemcitabine vs. long-term intravesical epirubicin in the treatment of moderate to high-risk non-muscle-invasive bladder cancer: a pilot study;Holistic Integrative Oncology;2024-02-20

3. Single-Dose Post-Office Fulguration Mitomycin C Instillation Appears to Improve Recurrence-Free Survival in Patients With Low-Grade Noninvasive Bladder Cancer;Clinical Genitourinary Cancer;2023-10

4. Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective;Expert Review of Clinical Pharmacology;2023-06-03

5. Clinical Effect of the Combination of Compound Kushen Injection and Gemcitabine on Postoperative Patients with Non-Muscle Invasive Bladder Cancer and Its Influence on Serum-Related Factors;Archivos Españoles de Urología;2023